Literature DB >> 25190241

20 years of cardiac resynchronization therapy.

Francisco Leyva1, Seah Nisam2, Angelo Auricchio3.   

Abstract

Cardiac resynchronization therapy (CRT) is an accepted treatment for patients with heart failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. It has been revolutionary for patients with advanced HF whose only previous option was cardiac transplantation, and it is now a realistic option for patients with mild HF. The development of CRT also has united the previously disparate cardiological subspecialties of electrophysiology and HF. This review, written on the occasion of the 20th anniversary of the first clinical use of CRT for HF, takes a historical perspective on CRT's evolution from "bench to bedside." We also comment on the task faced by electrophysiologists and HF specialists as they make this life-saving therapy available to an increasing number of eligible patients.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  artificial; atrial fibrillation; cardiac resynchronization therapy; defibrillators; electrophysiology; heart failure; implantable; pacemaker; ventricular remodeling

Mesh:

Year:  2014        PMID: 25190241     DOI: 10.1016/j.jacc.2014.06.1178

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

Review 1.  Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device.

Authors:  Jacinthe Boulet; Emmanuelle Massie; Blandine Mondésert; Yoan Lamarche; Michel Carrier; Anique Ducharme
Journal:  Curr Heart Fail Rep       Date:  2019-12

2.  123I-meta-Iodobenzylguanidine Imaging in Patients with Cardiac Resynchronization Therapy: Results are Intriguing, but Unknowns Remain.

Authors:  Anisiia Doytchinova; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2018-08-01       Impact factor: 5.952

3.  Cardiac resynchronization therapy update: evolving indications, expanding benefit?

Authors:  C Butcher; Y Mareev; V Markides; M Mason; T Wong; J G F Cleland
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 4.  Electrical manipulation of the failing heart.

Authors:  Valerio Zacà; Theodore Murphy; Mauro Biffi
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 5.  Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.

Authors:  Wei-Ping Sun; Chun-Lei Li; Jin-Cheng Guo; Li-Xin Zhang; Ran Liu; Hai-Bin Zhang; Ling Zhang
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

6.  Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.

Authors:  Neal A Chatterjee; Jagmeet P Singh; Jackie Szymonifka; Roderick C Deaño; Wai-Ee Thai; Bryan Wai; James K Min; James L Januzzi; Quynh A Truong
Journal:  Int J Cardiol       Date:  2015-12-11       Impact factor: 4.164

Review 7.  Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.

Authors:  Neal A Chatterjee; Attila Roka; Steven A Lubitz; Michael R Gold; Claude Daubert; Cecilia Linde; Jan Steffel; Jagmeet P Singh; Theofanie Mela
Journal:  Eur Heart J       Date:  2015-08-10       Impact factor: 29.983

8.  Association Between Industry Payments to Physicians and Device Selection in ICD Implantation.

Authors:  Amarnath R Annapureddy; Shady Henien; Yongfei Wang; Karl E Minges; Joseph S Ross; Erica S Spatz; Nihar R Desai; Pamela N Peterson; Frederick A Masoudi; Jeptha P Curtis
Journal:  JAMA       Date:  2020-11-03       Impact factor: 56.272

9.  Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.

Authors:  Neal A Chatterjee; Rasmus Borgquist; Yuchiao Chang; Jennifer Lewey; Vicki A Jackson; Jagmeet P Singh; Joshua P Metlay; Charlotta Lindvall
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983

Review 10.  Cardiac resynchronization therapy in heart failure patients: tough road but clear future.

Authors:  Ziyu Wang; Yongquan Wu; Junmeng Zhang
Journal:  Heart Fail Rev       Date:  2020-10-24       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.